Lv11
60 积分 2022-01-06 加入
Effect of Food on the Pharmacokinetics of Limertinib (ASK120067) and its Main Metabolite in Healthy Chinese Volunteers
7天前
已完结
Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial
28天前
已关闭
Two-year follow-up of relmacabtagene autoleucel in relapsed or refractory follicular lymphoma in RELIANCE study
1个月前
已完结
A novel agent, p-toluenesulfonamide, in the management of malignant pleural effusions
1个月前
已完结
A novel agent, p-toluenesulfonamide, in the management of malignant pleural effusions
1个月前
已完结
Advances and challenges in targeting FGFR signalling in cancer
2个月前
已完结
Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group
2个月前
已完结
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial
3个月前
已完结
Bone metastasis: mechanisms, therapies, and biomarkers
3个月前
已完结
The similarity of pharmacokinetics, pharmacodynamics, safety, and immunogenicity between recombinant fully human anti-RANKL monoclonal antibody injection (MW032) and denosumab (Xgeva®) in healthy Chinese subjects: A single-center, randomized, double-blind, single-dose, parallel-controlled clinical study
3个月前
已完结
皖公网安备34019202002308
